多抗药性和广泛抗药性结核病:对全球结核病控制的威胁
Neel R Gandhi1, Paul Nunn, Keertan Dheda
1Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, New York, NY 10467, USA. neelgandhi@alumni.williams.edu
Lancet (London, England)
|May 22, 2010
概括
耐多药结核病 (MDR TB) 是一个日益严重的威胁,在全球范围内发现和治疗的病例很少. 紧急改善诊断,治疗和国家政策是应对这一全球健康挑战的关键.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 全球卫生安全 全球卫生安全
背景情况:
- 全球减少药物敏感结核病的进展受到多抗药 (MDR) 和广泛抗药 (XDR) 结核病的兴起的威胁.
- 目前的应答率不足,估计MDR结核病例的低百分比在全球范围内被发现并接受治疗.
研究的目的:
- 突出各国对MDR和XDR结核病日益增长的威胁的缓慢反应.
- 强调需要提高实验室容量,感染控制和治疗计划.
- 强调国家政策和卫生系统改善对抗耐药结核病的重要性.
主要方法:
- 全球结核病发病率和治疗数据的分析.
- 对MDR和XDR结核病的现有诊断技术和药物的审查.
- 检查成功的国家一级策略的MDR结核病控制.
主要成果:
- 据估计,2008年只有7%的MDR结核病例被发现并报告给世卫组织,其中只有五分之一得到了适当的治疗.
- 对MDR和XDR结核病的治疗比对药物敏感结核病的治疗要昂贵得多,而且不那么成功.
- 一些国家表明,现有的技术可以在十年内逆转MDR结核病流行.
结论:
- 对MDR和XDR结核病的诊断和治疗进行大规模扩展至关重要,以防止耐药菌株占主导地位.
- 实验室能力,感染控制和结核病控制计划的重大改进是必要的.
- 对国家政策的承诺,卫生系统的加强和对治疗的财政可用性至关重要,特别是在负担较高的国家.
相关概念视频
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
